NewBorn Screening Forms

The contract involves the procurement and supply of specialized Newborn Screening (NBS) forms by the Georgia Department of Public Health, established under the State Purchasing Act. The primary objective is to secure a qualified supplier capable of producing six-part, high-quality, FDA-approved, ISO 9001-2008 certified forms constructed with CDC-certified filter paper (Ahlstrom 226 or Whatman 903) for blood spot collection. The forms must meet stringent construction, formatting, and size specifications, including features such as sequential numbering, bar codes, pressure-sensitive components, and a minimum shelf life of 24 months. The contractor is responsible for maintaining an emergency inventory of at least 10,000 forms, ready to ship within 24 hours, and must be capable of implementing both minor and major form modifications upon approval, ensuring compliance with federal and state standards. The contractual obligations emphasize strict quality assurance, timely delivery, and regulatory compliance, with detailed requirements for sample submission, approval processes, and ongoing quality monitoring. The contractor must operate through an FDA-approved facility meeting ISO standards, assume full liability for non-conforming forms, and participate in quality reviews and defect investigations. The contract, effective from January 1, 2026, through December 31, 2026, with options for renewal, stipulates detailed performance metrics, reporting, and transition plans to ensure seamless service continuity. Payment is contingent upon the timely submission of approved forms, reports, and invoices, with specific provisions for inspection, acceptance, and delivery to the Decatur Central Laboratory. Overall, the agreement underscores the importance of high standards in form quality, regulatory adherence, and responsive service to support Georgia’s mandated newborn screening program.